Immunogenicity of SARS-CoV-2 mRNA intramuscular vaccination in patients with muscular disorders

Immunogenicity of SARS-CoV-2 mRNA intramuscular vaccination in patients with muscular disorders

BackgroundsLittle clinical data is available on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in patients with muscular disorders (MDs). The immunogenicity of SARS-CoV-2 vaccines against MDs, in particular, remains unknown. Thus, this study aimed to confirm the immunogenicity and safe...

Full description

Bibliographic Details
Main Authors: Ryousuke Kasai, Michinori Funato, Kanako Maruta, Kunihiko Yasuda, Hiroshi Minatsu, Junji Ito, Kazuhiro Takahashi
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Immunology
Subjects:
COVID-19
muscular disorder
severe motor and intellectual disabilities
immunization
antibody responses
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1103196/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1103196/full

Similar Items